💨 Abstract

The FDA approved Novavax's COVID-19 vaccine but with unusual restrictions, allowing it only for adults 65 and older or those aged 12-64 with health conditions. This decision contrasts with Pfizer and Moderna vaccines, which are fully licensed for everyone 12 and older and authorized for children as young as 6 months.

Courtesy: wtop.com